IceCure Medical (ICCM) Gross Margin (2020 - 2026)

IceCure Medical (ICCM) has 7 years of Gross Margin data on file, last reported at 32.38% in Q1 2026.

• On a quarterly basis, Gross Margin rose 231.0% year-over-year to 32.38% in Q1 2026; TTM through Mar 2026 was 36.55%, a 622.0% decrease from a year earlier, with the FY2025 full-year figure at 36.28%, down 781.0% from the prior year.
• Gross Margin for Q1 2026 stood at 32.38%, down from 46.91% in the prior quarter.
• Over the last five years, Gross Margin for ICCM reached as high as 58.1% in Q1 2022 and fell as low as 7.03% in Q3 2023.
• Historically, Gross Margin has averaged 38.35% across 5 years, with a median of 45.07% in 2023.
• Across the five-year window, Gross Margin sank 3322 bps in 2023 and jumped 4253 bps in 2024, its largest moves.
• Year by year, Gross Margin stood at 49.09% in 2022, then dropped by 8 bps to 45.34% in 2023, then increased by 5 bps to 47.66% in 2024, then declined by 2 bps to 46.91% in 2025, then plunged by 31 bps to 32.38% in 2026.
• Per Business Quant data, the three most recent Gross Margin figures were 32.38% in Q1 2026, 46.91% in Q4 2025, and 32.59% in Q3 2025.